Insightalyst: FDA Draft Investigator Responsibilities Guidance
On September 30, 2021, the U.S. Food and Drug Administration (FDA) issued new draft guidance, Investigator Responsibilities—Safety Reporting for Investigational Drugs and Devices. This draft guidance addresses how
investigators must assess and report adverse events to ensure participant safety in drug and device studies.